Literature DB >> 2564366

A role for dopamine as an endogenous protective factor in the rat stomach.

W K MacNaughton1, J L Wallace.   

Abstract

Application of an irritant to the surface of the gastric mucosa confers protection against subsequent application of a damaging agent ("adaptive cytoprotection"). The possibility that this adaptive response is mediated via the release of nonprostaglandin mediators was examined using an ex vivo gastric chamber model, in which the irritant (1 M sodium chloride) could be applied to only one-half of the exposed mucosa. Rats were pretreated with indomethacin and one of various receptor antagonists, including cimetidine, pyrilamine, atropine, propranolol, phentolamine, cyproheptadine, haloperidol, and BN52021. In control studies, application of hypertonic saline to the left side of the mucosa reduced hemorrhagic damage induced by subsequent application of 70% ethanol by 71% +/- 4% (p less than 0.01). Of the receptor antagonists tested, only cyproheptadine and haloperidol significantly attenuated the degree of protection afforded by exposure to hypertonic saline. Subsequent dose-response studies with other serotonergic and dopaminergic antagonists suggested that dopaminergic receptors are involved in the adaptive response to the irritant. Topical application of a dopamine agonist, bromocriptine, or L-beta-3,4-dihydroxyphenylalanine, significantly reduced the extent of damage induced by subsequent application of 70% ethanol. The results of the gastric chamber studies were confirmed in conscious rats in which the irritant, dopamine agonist, and ethanol were administered orally. These results therefore suggest a role for endogenous dopamine as a mediator of the adaptive cytoprotection phenomenon.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564366     DOI: 10.1016/0016-5085(89)91612-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue.

Authors:  S Basu; P S Dasgupta
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Gastric contents retained in rat stomach following mild irritant exposure contribute to adaptive cytoprotection.

Authors:  M A Balaa; C Turnage
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

Review 3.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

4.  A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine.

Authors:  E Mezey; G Eisenhofer; G Harta; S Hansson; L Gould; B Hunyady; B J Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

5.  Dopaminergic control of gastric mucosal blood flow in humans. A study with endoscopic laser Doppler flowmetry coupled with gastric submucosal drug injection.

Authors:  M Kaise; H Echizen; T Ishizaki
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

6.  Catecholamine concentrations in biopsied gastroduodenal tissue specimens of patients with duodenal ulcer.

Authors:  M Kaise; H Echizen; N Umeda; T Ishizaki
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 7.  Role of dopamine and other stimuli of mucosal bicarbonate secretion in duodenal protection.

Authors:  G Flemström; B Säfsten
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

8.  Effects of dopamine and alpha-2 adrenoreceptor blockade on L-dopa and cholecystokinin-induced gastroprotection.

Authors:  J M Cross; D W Mercer; J Gunter; T A Miller
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

9.  Catecholamine-synthesizing enzymes in the rat stomach.

Authors:  N Bäck; M Ahonen; S Soinila; E Kivilaakso; T Kiviluoto
Journal:  Histochem Cell Biol       Date:  1995-07       Impact factor: 4.304

10.  [Concept of stress ulcer prevention. Is re-thinking necessary?].

Authors:  S Kress; D Schilling; J F Riemann
Journal:  Med Klin (Munich)       Date:  1998-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.